Last reviewed · How we verify
NCT05850845
Study on the Application of Hyperspectral Imaging Technique in CTX Treatment of IMN
trial testing Microscopic hyperspectral imaging system in Hyperspectral Imaging in 40 participants. Status unknown.
20 July 2023
Quick facts
| Lead sponsor | Qianfoshan Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 25 June 2023 |
| Primary completion | 20 July 2023 |
| Estimated completion | 30 December 2023 |
Drugs / interventions tested
- Microscopic hyperspectral imaging system
Conditions studied
- Hyperspectral Imaging — all drugs for Hyperspectral Imaging →
- Idiopathic Membranous Nephropathy — all drugs for Idiopathic Membranous Nephropathy →
- Cyclophosphamide — all drugs for Cyclophosphamide →
Sponsor
Qianfoshan Hospital
Who can join
Adults 18 to 90, any sex, with Hyperspectral Imaging or Idiopathic Membranous Nephropathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Investigators propose hyperspectral imaging analysis as a method to distinguish the efficacy of hormone-combined cyclophosphamide therapy for PMN, and classify sensitive and insensitive patients treated with hormone-combined cyclophosphamide regimen. A variety of machine learning models were used to prove that hyperspectral imaging technology could assist patients in selecting the optimal treatment plan, and further explore the predictive indicators of PMN treatment effect.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05850845
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Microscopic hyperspectral imaging system
Trials testing the same drug.
- NCT05797051 — Application of Hyperspectral Imaging in the Diagnosis of Glomerular Diseases · unknown
Other Qianfoshan Hospital trials
Trials by the same sponsor.
- NCT05727618 — The Effect of Pituitrin on the Patients With Pulmonary Hypertension Undergoing Cardiac Surgery · NA · suspended
- NCT06837831 — Mepilex Lite Dressings for the Treatment of Acute Radiation Dermatitis of Anal Canal Skin · NA · recruiting
- NCT07260760 — Clinical Comprehensive Evaluation of Neuroprotective Drugs for Acute Ischemic Stroke · not yet recruiting
- NCT07362667 — A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA · recruiting
- NCT07271849 — Nalbuphine Timing Effects on Hemodynamics and Analgesia in Elderly Patients · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05850845 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Qianfoshan Hospital
- Last refreshed: 9 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05850845.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing